Trexquant Investment LP Ligand Pharmaceuticals Inc Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$69.53 - $79.33 $341,809 - $389,986	4,916 Added 30.07%	21,267 $1.53 Million
Q1 2023 May 15, 2023	SELL	$65.67 - $77.08 $471,379 - $553,280	-7,178 Reduced 30.51%	16,351 $1.2 Million
Q4 2022 Feb 13, 2023	BUY	$61.72 - $96.74 $481,107 - $754,088	7,795 Added 49.54%	23,529 $1.57 Million
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $110 - $1.19 Million	11,060 Added 236.63%	15,734 $1.36 Million
Q2 2022 Aug 11, 2022	BUY	$74.52 - $117.06 $348,306 - $547,138	4,674 New	4,674 $417,000
Q1 2022 May 13, 2022	SELL	$94.99 - $151.56 $349,563 - $557,740	-3,680 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$127.69 - $165.85 $469,899 - $610,328	3,680 New	3,680 $568,000
Q4 2020 Feb 11, 2021	SELL	$80.55 - $106.05 $532,516 - $701,096	-6,611 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$89.56 - $126.72 $99,322 - $140,532	1,109 Added 20.16%	6,611 $630,000
Q2 2020 Aug 07, 2020	SELL	$68.28 - $123.65 $457,680 - $828,825	-6,703 Reduced 54.92%	5,502 $615,000
Q1 2020 May 08, 2020	BUY	$63.37 - $107.88 $773,430 - $1.32 Million	12,205 New	12,205 $888,000
Q4 2019 Feb 12, 2020	SELL	$96.94 - $113.59 $322,228 - $377,573	-3,324 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$86.25 - $120.16 $67,447 - $93,965	-782 Reduced 19.05%	3,324 $331,000
Q2 2019 Aug 09, 2019	BUY	$107.38 - $129.34 $440,902 - $531,070	4,106 New	4,106 $469,000
Q1 2019 May 13, 2019	SELL	$105.93 - $142.47 $2.86 Million - $3.84 Million	-26,987 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$128.36 - $272.13 $2.72 Million - $5.77 Million	21,214 Added 367.47%	26,987 $3.66 Million
Q3 2018 Nov 09, 2018	BUY	$211.18 - $274.49 $1.22 Million - $1.58 Million	5,773 New	5,773 $1.59 Million

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account